Overview

Combining Lesinurad With Allopurinol in Inadequate Responders

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This study that compare the serum uric acid lowering effects, clinical benefits, and safety of lesinurad in combination with allopurinol to allopurinol alone in subjects with gout who have had an inadequate response to allopurinol.
Phase:
Phase 3
Details
Lead Sponsor:
Ardea Biosciences, Inc.
Treatments:
Allopurinol
Lesinurad